- Report
- October 2025
- 194 Pages
Global
From €3153EUR$3,545USD£2,774GBP
€3503EUR$3,939USD£3,082GBP
- Report
- March 2025
- 200 Pages
Global
From €3993EUR$4,490USD£3,513GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1423EUR$1,600USD£1,252GBP
€1779EUR$2,000USD£1,565GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1423EUR$1,600USD£1,252GBP
€1779EUR$2,000USD£1,565GBP
- Report
- March 2025
- 150 Pages
Global
From €3424EUR$3,850USD£3,012GBP
€4313EUR$4,850USD£3,795GBP
- Report
- November 2025
Global
From €4358EUR$4,900USD£3,834GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1423EUR$1,600USD£1,252GBP
€1779EUR$2,000USD£1,565GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1067EUR$1,200USD£939GBP
€1334EUR$1,500USD£1,174GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1067EUR$1,200USD£939GBP
€1334EUR$1,500USD£1,174GBP
- Report
- December 2025
- 386 Pages
Global
From €5203EUR$5,850USD£4,577GBP
- Report
- June 2025
- 200 Pages
Global
From €2480EUR$2,789USD£2,182GBP
- Report
- April 2025
- 130 Pages
Global
From €3666EUR$4,123USD£3,225GBP
€4313EUR$4,850USD£3,795GBP
- Report
- November 2025
Global
From €4358EUR$4,900USD£3,834GBP
- Report
- July 2025
- 175 Pages
Global
From €3993EUR$4,490USD£3,513GBP
- Report
- December 2025
- 381 Pages
Global
From €5203EUR$5,850USD£4,577GBP
- Report
- December 2025
- 273 Pages
Global
From €5203EUR$5,850USD£4,577GBP
- Report
- December 2025
- 372 Pages
Global
From €5203EUR$5,850USD£4,577GBP
- Report
- December 2025
- 384 Pages
Global
From €5203EUR$5,850USD£4,577GBP
- Report
- December 2025
- 276 Pages
Global
From €5203EUR$5,850USD£4,577GBP
- Report
- December 2025
- 506 Pages
Global
From €5203EUR$5,850USD£4,577GBP

The Neuropathic Pain Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Neuropathic pain drugs are used to treat chronic pain caused by nerve damage, such as diabetic neuropathy, postherpetic neuralgia, and trigeminal neuralgia. These drugs are typically divided into two categories: anticonvulsants and antidepressants. Anticonvulsants are used to reduce the intensity of nerve pain, while antidepressants are used to reduce the frequency of nerve pain. Commonly prescribed neuropathic pain drugs include pregabalin, gabapentin, duloxetine, and amitriptyline.
Some companies in the Neuropathic Pain Drug market include Pfizer, GlaxoSmithKline, Eli Lilly, and Novartis. Show Less Read more